TRAVERE THERAPEUTICS, INC. (TVTX)
Clinical trial NCT04663204 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2025-03-31 → 2027-12-31 3. primary completion date: 2025-03-31 → 2027-12-31 4. enrollment: 12 → 24 participants
Clinical trial NCT04663204 updates: 1. status: ACTIVE_NOT_RECRUITING → RECRUITING 2. completion date: 2025-03-31 → 2027-12-31 3. primary completion date: 2025-03-31 → 2027-12-31 4. enrollment: 12 → 24 participants
📉 **NEGATIVE** • Low confidence analysis (53%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (45%) **Content type:** Clinical